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Abstract. 
 
g
 
-Filamin, also called ABP-L, is a ﬁlamin
 
isoform that is speciﬁcally expressed in striated mus-
cles, where it is predominantly localized in myoﬁbrillar
Z-discs. A minor fraction of the protein shows subsar-
 
colemmal localization. Although 
 
g
 
-ﬁlamin has the same
overall structure as the two other known isoforms, it is
the only isoform that carries a unique insertion in its
immunoglobulin (Ig)-like domain 20. Sequencing of the
genomic region encoding this part of the molecule
shows that this insert is encoded by an extra exon. Tran-
sient transfections of the insert-bearing domain in skel-
etal muscle cells and cardiomyocytes show that this sin-
gle domain is sufﬁcient for targeting to developing and
mature Z-discs. The yeast two-hybrid method was used
to identify possible binding partners for the insert-bear-
ing Ig-like domain 20 of 
 
g
 
-ﬁlamin. The two Ig-like do-
 
mains of the recently described 
 
a
 
-actinin–binding Z-disc
protein myotilin were found to interact directly with
this ﬁlamin domain, indicating that the amino-terminal
end of 
 
g
 
-ﬁlamin may be indirectly anchored to 
 
a
 
-acti-
nin in the Z-disc via myotilin. Since defects in the myo-
tilin gene were recently reported to cause a form of au-
tosomal dominant limb-girdle muscular dystrophy, our
ﬁndings provide a further contribution to the molecular
understanding of this disease.
Key words: ﬁlamin • myotilin • limb-girdle muscular
dystrophy • myoﬁbrils • Z-disc proteins
 
Introduction
 
The three-dimensional structure of actin-based macromo-
lecular assemblages largely depends on the activity of a
plethora of actin-binding proteins. Thus, microfilaments
can be as short as 13 actin monomers in the submembrane-
ous cytoskeleton of erythrocytes, while they can reach sev-
eral micrometers in length, for instance in the stress-fibers
of cultured cells. Strictly bundled filaments in microvilli or
stress fibers oppose to loose networks with very little ap-
parent regularity, as found in the terminal web of epithe-
lial cells or the leading edge of motile cultured cells.
Mostly, these distinct structures can be attributed to the
specific activity of individual actin filament-binding pro-
teins or protein families (Ayscough, 1998). The various
isoforms or individual family members often exhibit strik-
ingly different expression patterns and/or subcellular lo-
calizations. The molecular basis for the distinct functional-
ity of highly similar but distinct variants of a protein is,
however, little understood. One example for such versatile
proteins that should allow us to analyze isoform-specific
cellular functions is the filamin family (Hock, 1999). These
ubiquitously distributed actin–cross-linking proteins were
described to cause bundling of actin filaments (Wang et
al., 1975; Wang and Singer, 1977; Brotschi et al., 1978), a
situation compatible with filamin’s stress-fiber localization
(Mittal et al., 1987) and with its suggested role in organiz-
ing the contractile units of smooth muscle cells (Small et
al., 1986). Conversely, a number of studies emphasized fil-
amin’s role in organizing the cortical actin filaments of, for
instance, blood platelets and cultured cells (Cunningham
et al., 1992). This latter function is exemplified further by
the documentation of interactions between filamins and
several transmembrane proteins: the cytoplasmic portion
of the glycoprotein Ib IX complex, the receptor for von
Willebrand factor (Fox, 1985; Okita et al., 1985; Meyer et
 
al., 1997; Takafuta et al., 1998; Xu et al., 1998), 
 
b
 
1-integrin
(Pfaff et al., 1998; Loo et al., 1998), 
 
b
 
2-integrin (Sharma et
al., 1995), caveolin-1 (Stahlhut and van Deurs, 2000), and
 
g
 
- and 
 
d
 
-sarcoglycan (Thompson et al., 2000) were all
identified as ligands for filamins. Intracellular proteins
that bind to filamin include furin (Liu et al., 1997), preseni-
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lin-1 (Zhang et al., 1998) and SEK-1, the activator of
SAPK (Marti et al., 1997). This leaves us with the need to
define distinct functions of certain filamin variants in cer-
tain cell types. Until now, three human filamin gene paral-
ogues have been identified: 
 
FLNA
 
 encodes 
 
a
 
-filamin (also
called ABP-280) and maps to the chromosomal position
Xq28 (Gorlin et al., 1990, 1993; Maestrini et al., 1993).
 
FLNB
 
 codes for 
 
b
 
-filamin (also called ABP-278) and was
located at chromosome 3p14.3 (Takafuta et al., 1998; Xu
et al., 1998; Bröcker et al., 1999). 
 
FLNC
 
 encodes 
 
g
 
-filamin
(also called ABP-L or FLN2) and was mapped to chromo-
some 7q32-q35 (Gariboldi et al., 1994; Xie et al., 1998).
Variability, however, goes even further because differen-
tial splicing has already been demonstrated for all three
genes (Maestrini et al., 1993; Xie et al., 1998; Xu et al.,
1998). The exact knowledge of the full complement of fil-
amin isoforms expressed will have to await the detailed
characterization of the entire gene family.
Cross-striated muscles offer an excellent system to ad-
dress several questions regarding filamin isoform-specific
cellular functions. The 
 
g
 
-filamin isoform harboring a
unique insertion of 78 amino acids was shown to be ex-
pressed specifically in muscular tissues (Maestrini et al.,
1993; Xie et al., 1998; van der Ven et al., 2000). Its upregu-
lation during the initial stages of myocyte differentiation
and its localization predominantly at the periphery of
Z-discs implied an important role of this filamin variant
during myofibrillogenesis (van der Ven et al., 2000). In
addition, the recently documented binding to sarcoglycans
(Thompson et al., 2000) and the assignment of a subtype of
limb-girdle muscular dystrophy (LGMD)
 
1
 
 to the same re-
gion of chromosome 7 where the 
 
FLNC
 
 gene was mapped
(Speer et al., 1999) made 
 
g
 
-filamin an interesting candidate
for a muscular disease gene. Our analysis that focused on a
differentially spliced muscle-specific region of this polypep-
tide demonstrated myofibrillar targeting by this portion. At
the same time, we identified myotilin (Salmikangas et al.,
1999) as a novel filamin ligand. This report therefore sheds
new light on the molecular basis of LGMD.
 
Materials and Methods
 
Antibodies
 
The following antibodies were used in this study: (a) RR90, a mouse mAb
(immunoglobulin A, IgA) recognizing the aminoterminal region of 
 
g
 
- and
 
a
 
-filamin (van der Ven et al., 2000; this report). (b) mAb 1680, a mouse
mAb (IgG1) raised against the carboxy terminal 90-kD fragment of plate-
let filamin (Wang et al., 1996), purchased from Chemicon International. In
this report, we show that this antibody is specific for 
 
a
 
-filamin (see below).
(c) BM-75.2, a mouse mAb (IgM) recognizing all isoforms of 
 
a
 
-actinin
(Abd-el-Basset et al., 1991), purchased from Sigma-Aldrich. (d) T7 Tag
antibody, a mouse mAb (IgG2b) purchased from Novagen, specific for the
aminoterminal end of the T7 major capsid protein. This antibody was used
to detect epitope-tagged proteins expressed by the pCMV5-T7 and
pET23-T7 vectors, respectively. (e) T12, a mouse mAb (IgG1) directed
against domains I2–I4 just carboxy-terminal from the inextensible Z-disc
region of titin (Fürst et al., 1988). (f) EA53, a monoclonal mouse antibody
(IgG1) specific for sarcomeric 
 
a
 
-actinin (Goncharova et al., 1992), pur-
chased from Sigma-Aldrich. (g) YL1/2, a rat mAb directed against the car-
boxy terminus of tyrosinated tubulin (Wehland et al., 1983). This antibody
(a kind gift of Dr. J. Wehland, Gesellschaft fur Biotechnologische For-
schung, Braunschweig, Germany) was used to detect epitope-tagged pro-
 
teins expressed using the pET23-EEF vector described below. (h) 12CA5,
a mouse mAb directed against the influenza virus hemagglutinin epitope
(HA-tag) was purchased from Roche Diagnostics, and was used to detect
the GAL4 AD-HA-epitope fusion proteins upon expression in yeast cells.
(i) LexA mouse mAb (CLONTECH Laboratories, Inc.) was used to de-
tect LexA-fusion proteins in yeast extracts. (j) Rabbit polyclonal antibody
948, affinity purified from a rabbit antiserum raised against a peptide en-
compassing residues 353–369 of myotilin (Salmikangas et al., 1999).
 
Cell Cultures
 
Human skeletal muscle cells were isolated and cultured essentially as de-
scribed before (van der Ven et al., 1992, 1993). In brief, enzymatically iso-
lated satellite cells from normal human skeletal muscle biopsies, passaged
two to five times and frozen in liquid nitrogen, were quickly thawed and
plated on glass coverslips in DME supplemented with 20% FCS, 2% Ul-
troser G, 100 U/ml penicillin and 1 
 
m
 
g/ml streptomycin (all from Life
Technologies). Cells were grown until near confluency. Differentiation of
the cells was induced by changing the high nutrition medium to differenti-
ation medium (DME, 0.4% Ultroser G and antibiotics as above).
C2C12 cells (ECACC # CB2438) were cultured in DME supplemented
with 15% FCS and antibiotics. Differentiation was induced as described
for human skeletal muscle cells.
Neonatal rat cardiomyocytes were prepared exactly as described before
(Sen et al., 1988; Komiyama et al., 1996). Cells were plated in 35-mm cul-
ture dishes in 68% DME/17% medium M199 supplemented with 10%
horse serum, 5% FCS, 4 mM 
 
L
 
-glutamine, and antibiotics as above.
Ptk2 cells (ECACC # CB2059) were cultured in DME supplemented
with 10% FCS, nonessential amino acids, and antibiotics as above.
 
Transient Transfection Experiments
 
C2C12 cells were seeded the day before transfection and grown on glass
coverslips placed in a 35-mm culture dish to 
 
z
 
80% confluency. The cells
were transfected using lipofectamine according to the manufacturer’s in-
structions (Life Technologies), except that 5 
 
m
 
g plasmid DNA and 10 
 
m
 
l
lipofectamine were used per culture dish. Ptk2 cells were transfected using
Fugene6, according to the manufacturer’s instructions (Roche Diagnos-
tics). Transfected C2C12 cells were induced to differentiate by changing
the culture medium to differentiation medium the day after transfection,
and cells were allowed to differentiate for 2–6 d. Transfected Ptk2 were
analyzed for expression of the recombinant protein 24–48 h after transfec-
tion. Cells were fixed and stained as described below.
Transfections of neonatal rat cardiomyocytes were performed using a
modified calcium-phosphate protocol as described (Komiyama et al.,
1996). In brief, 4 
 
3
 
 10
 
6
 
 cardiomyocytes were seeded per 35-mm culture
dish and were allowed to grow for 
 
z
 
24 h at 10% CO
 
2
 
. 1–2 
 
m
 
g of DNA was
diluted with H
 
2
 
O to a total volume of 135 
 
m
 
l and, after vortexing, 15 
 
m
 
l of a
2.5 M CaCl
 
2
 
 solution was added. While vortexing, 150 
 
m
 
l of 2
 
3
 
 BES (
 
N,N
 
-
bis[2-hydroxyethyl]-2 aminoethane sulfonic acid)-buffered saline (50 mM
BES, 1.5 mM Na
 
2
 
HPO
 
4
 
, 280 mM NaCl, pH 6.7) was added dropwise, and
the mixture was incubated for 12 min at room temperature. Subsequently,
the mixture was added dropwise to culture dishes containing 2 ml medium
and cells were incubated at 37
 
8
 
C, 3% CO
 
2 
 
for 5 h. After transfection, cells
were washed twice with Tris-buffered saline, and the medium was changed
to a low nutrition medium consisting of 78% DME/20% medium 199 sup-
plemented with 1% horse serum, 0.1 mM phenylephrine (Sigma-Aldrich),
4 mM 
 
L
 
-glutamine and antibiotics as above, and the cells were kept in this
medium for 72 h, at 10% CO
 
2
 
 until they were fixed and stained.
 
Immunofluorescence Microscopy
 
At different time points after the switch of media, human skeletal muscle
cells and C2C12 cells were fixed for 
 
z
 
5 min in methanol and subsequently
for 30 s in acetone, both at 
 
2
 
20
 
8
 
C. Ptk2 cells were fixed identically. After
air drying, cells were immediately used or frozen at 
 
2
 
80
 
8
 
C. Cardiomyo-
cytes were fixed with 3% paraformaldehyde in PBS for 15 min. Subse-
quently, they were washed with PBS, treated with 0.1 M glycine in PBS for
3 min, and permeabilized with 0.2% Triton X-100 in PBS for 15 min. Be-
fore application of the antibodies (diluted in 1% BSA in PBS), cardiomyo-
cytes were blocked with 5% normal goat serum, 1% BSA in PBS for 20
min. Double immunofluorescence assays were performed using mixtures
of the primary antibodies followed by a mixture of the matching second-
ary antibodies (Southern Biotechnology Associates, Inc.; Jackson Immu-
noResearch Laboratories; Cappel) using standard procedures (van der
Ven et al., 1993). The cells were embedded in Mowiol or in Tris-buffered
 
1
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glycerol containing 50 mg/ml 
 
N
 
-propyl gallate (Sigma-Aldrich). The
stained cells were analyzed using an Axiophot microscope (Carl Zeiss,
Inc.) equipped with a cooled CCD camera, or with a confocal microscope
(Leica) as described (Auerbach et al., 1999).
 
Construction of Expression Constructs
 
The prokaryotic expression vector pET-23a (Novagen) was modified by
the introduction of an immunotag directly following the His6 tag, resulting
in the vector called pET23-EEF. This immunotag consists of merely three
amino acids (glutamic acid–glutamic acid–phenylalanine, EEF) and is rec-
ognized by the rat mAb YL1/2 (Wehland et al., 1983). Expressed proteins
therefore carry a carboxyterminal His6 tag, allowing purification on Ni-
agarose (QIAGEN) columns, while at the same time the EEF tag allows
for immunodetection with mAb YL1/2. Another variant of the original
pET-23a vector (pET23-T7) resulted in an amino-terminal T7 tag added
to the expressed protein. Thus, expressed proteins carry an amino-termi-
nal T7 tag enabling immunodetection with the T7 tag antibody
(Novagen), and a carboxyterminal His6 tag.
cDNA fragments covering different parts of 
 
a
 
- and 
 
g
 
-filamin (see Fig.
1) were obtained by reverse transcription–PCR using total RNA purified
from nondifferentiated or differentiated cultured human skeletal muscle
cells, respectively, as a template using the “Expand long template PCR
system” according to the manufacturer’s instructions (Roche Diagnos-
tics). These fragments were used to amplify and subclone truncated vari-
ants of both proteins in the prokaryotic expression vector pET23-EEF
and/or the eukaryotic expression vector pCMV5-T7 (Obermann et al.,
1998) using forward primers containing an MluI site, and reverse primers
containing a SalI site adjacent to the sequence homologous to the desired
filamin sequence. In the case of 
 
b
 
-filamin, a full-length cloned cDNA
(kindly provided by Drs. S. Shapiro and T. Takafuta, Cardeza Foundation
for Hematologic Research, Department of Medicine, Jefferson Medical
College, Philadelphia, PA) was used as a template to amplify cDNA frag-
ments (see Fig. 1). Double digested PCR fragments were ligated into the
correspondingly cut vectors. Similarly, truncated myotilin fragments (see
Fig. 1) were cloned in pET23-T7 for bacterial expression, or in pCMV5-T7
or pcDNA3.1/CT-GFP (Invitrogen) to allow the expression of T7- or
green fluorescent protein (GFP)–tagged myotilin fragments in eukaryotic
cells, respectively. The human nonmuscle
 
 
 
a
 
-actinin cDNA cloned in the
pEGFP-N3 vector (CLONTECH Laboratories, Inc.) was a kind gift of Dr.
C. Otey (University of North Carolina, Chapel Hill, NC). Constructs were
transformed to and propagated in 
 
Escherichia coli
 
 JM 109 bacteria. DNAs
were purified using the Plasmid Kit (QIAGEN). Constructs in both modi-
fied pET vectors were transformed to 
 
E
 
. 
 
coli
 
 BL21(DE3)pLysS cells. Ex-
pression and purification of recombinant proteins were carried out essen-
tially as described before (Obermann et al., 1997, 1998; see also below).
 
Genomic PCR
 
Genomic fragments encoding specific parts of the 
 
FLNC
 
 gene were ampli-
fied by PCR (Saiki et al., 1985) using the Expand long template PCR sys-
tem with DNA isolated from cultured normal human myoblasts using the
blood and cell culture DNA Kit (QIAGEN) as a template. Amplified frag-
ments were cloned in the pCR Vector using a TA cloning kit (Invitrogen)
and sequenced.
 
Yeast Two-Hybrid Library Screening
 
Portions of the 
 
g
 
-filamin cDNA comprising the Ig-like domain 20 (includ-
ing the unique insertion) with one or two of the flanking domains (Fig. 1)
were amplified by PCR and cloned into a modified pLexA vector contain-
ing a new multicloning site (Stenmark et al., 1995; Young et al., 1998). The
resulting plasmids were pretransformed into the 
 
Saccharomyces cerevisiae
 
L40 reporter strain (Vojtek et al., 1993) using a modified lithium acetate
protocol (see protocol 01525; Elsevier’s Trends Journals Technical Tips
Online, available at http://tto.trends.com). Subsequently, this strain was
cotransformed with a human skeletal muscle cDNA library in the vector
pACT2 (Matchmaker cDNA library HL4047AH; CLONTECH Labora-
tories, Inc.). Selection for HIS3 reporter gene activation was performed
on agar plates without histidine, leucine, or tryptophane (SD-LWH agar)
according to the Matchmaker protocol. Colonies growing after 
 
z
 
5 d at
30
 
8
 
C were screened for activity of the LacZ reporter gene in filter assays.
Plasmids from positive clones were purified and transferred to 
 
E
 
.
 
 coli
 
JM109 or DH5
 
a
 
 by electroporation (Matchmaker protocol). For submap-
ping the interaction between filamin and myotilin, constructs encoding
distinct portions of both proteins were cloned into pGAD10AD and
Figure 1. Domain organization
of the filamins and of myotilin,
and recombinant constructs
used for transfection assays. A
emphasizes the general modu-
lar organization of filamins: the
actin binding head domain
(ABD) is followed by 24 Ig-like
modules (identified by numbers
between the boxes). Stretches
of unique sequence, so-called
hinge regions, are found be-
tween Ig-like domains 15 and
16, as well as between domains
23 and 24. Muscle g-filamin,
however, lacks this insertion,
which might make the molecule
less flexible. A conspicuous dif-
ference between g-filamin and
the other members of the fil-
amin family is a unique insertion
in the middle of Ig-like domain
20. Constructs derived from a-
or  g-filamin, which were used
for the experiments of this work,
are shown schematically above
and below the respective mother
molecules. For yeast two-hybrid
screens and for prokaryotic expression experiments, identical inserts were cloned into the respective vectors (see Materials and Meth-
ods). (B) A layout of the structure of myotilin is given. The molecule consists of a serine-rich amino terminal portion (S), followed by
two immunoglobulin-like domains (I) and a carboxyterminal “tail” sequence (T). Inserts were cloned into the respective vectors for
yeast two-hybrid experiments and for prokaryotic expression. (C) Legend to the domain symbols used in A and B. 
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pLexA vectors, respectively, and cotransformed into L40 yeast cells.
Growth on SD-LWH agar plates and activity of 
 
b
 
-galactosidase were as-
sayed as described above.
 
Immunoprecipitation
 
For coimmunoprecipitation experiments, a mixture of 0.5 mg of each re-
combinant protein was diluted in 20 mM Tris-HCl, pH 7.4, 150 mM NaCl,
1% Triton X-100, 1% BSA. After the addition of either 1 
 
m
 
g anti–EEF an-
tibody (YL1/2) or anti–T7 antibody, the mixture was incubated at 4
 
8
 
C for
60 min with gentle shaking. Subsequently, 5 
 
m
 
l GammaBind G Sepharose
(Amersham Pharmacia Biotech) was added, and the mixture was further
incubated for 30 min with gentle shaking. The sepharose beads were
washed three times with 20 mM Tris-HCl, pH 7.4, 500 mM NaCl, 1% Tri-
ton X-100, and once with 20 mM Tris-HCl, pH 7.4, 500 mM NaCl.
Sepharose bound immune complexes were sedimented twice through a su-
crose cushion (1 M sucrose in 20 mM Tris-HCl, pH 7.4, 500 mM NaCl),
and the beads were washed twice with 20 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 1% Triton X-100. Finally, beads were boiled in SDS-sample buffer,
and bead-associated proteins were separated by SDS-PAGE (Laemmli,
1970). Proteins were blotted to polyvinyl difluoride membrane using a
semidry blot apparatus (Bio-Rad Laboratories), and the precipitated pro-
teins were identified by immunodetection. The following combinations of
antibodies were used: (a) anti–T7 antibody (Novagen) and peroxidase-
conjugated goat anti–mouse secondary antibody (Jackson ImmunoRe-
search Laboratories); (b) anti–EEF antibody YL 1/2 and peroxidase-con-
jugated goat anti–rat secondary antibody (American Qualex). Reactions
were detected by enhanced chemiluminescence using “SuperSignal West
Pico Chemiluminescent Substrate” (Pierce Chemical Co.).
Coimmunoprecipitations from yeast cells expressing the HA-tagged
myotilin fragment fused to the GAL 4AD domain and the LexA-
 
g
 
-filamin
fusion protein were performed as previously described (Grönholm et al.,
1999). The anti–HA-tag antibody (12CA5) as well as the polyclonal anti–
myotilin antiserum (948) were used in a 1:500 dilution.
 
Results
 
The
 
 
 
g
 
-Filamin–specific Insertion in Domain 20 Is 
Encoded by an Individual Exon
 
To examine the genomic organization of the region encod-
ing the unique insertion within the Ig-like domain 20 of
 
g
 
-filamin, defined portions of the human 
 
FLNC 
 
gene were
amplified. Analysis of the length of the PCR products, and
comparison with the theoretical length of the products de-
rived from the cDNA sequence, showed that the product
representing the insertion of domain 20 alone did not differ
 
from the expected length, whereas all three other products,
which included sequences from the insert-harboring do-
main, were considerably longer (Fig. 2, A and B). This in-
dicated that at least one intron should be present between
the 5
 
9
 
 end of domain 20 and the insertion, and another in-
tron must be localized between the 3
 
9
 
 end of domain 20
and the insertion. To analyze the precise structure of this
part of the 
 
FLNC
 
 gene, the 
 
z
 
900-bp-long PCR product
yielded by amplification of the complete domain 20 was
cloned and sequenced. This revealed that the insertion
within domain 20 is encoded by a single exon with a length
of 243 bp. This exon is separated from the parts of the gene
that encode the 5
 
9
 
 and 3
 
9
 
 parts of domain 20 by introns
with a length of 136 and 196 bp, respectively (Fig. 2 C).
Figure 2. Analysis of the structure of the FLNC
gene encoding domain 20. (A) PCR products af-
ter amplification of human genomic DNA with
primers P1 and P4 (P1–P4), P1 and P3 (P1–P3),
P2 and P3 (P2–P3), and P2 and P4 (P2–P4). (B)
Horizontal lines represent the four PCR products
depicted in A, and the derived exon/intron struc-
ture of domain 20. Note that the primers used for
amplification (P1: GTCACCAACAGCCCCT-
TCAAG; P2: AAGGTGACCGGCGAGGGC-
CGC; P3: CACAGTGAACTGAAAGGGGCT;
P4: AGCGTCATCCGAGAGGGAGG) all had
a tail of nine additional basepairs to allow restric-
tion enzyme–based cloning. Therefore, the actual
length of the products was reduced by subtraction
of 18 basepairs. (C) Splice junctions and exon and
intron sizes of the part of the FLNC gene that en-
codes domain 20 are shown.
Figure 3. Characterization of the filamin antibodies. Total pro-
tein extracts from bacteria expressing the carboxyterminally im-
munotagged polypeptides indicated above each lane were sepa-
rated on a polyacrylamide gel and transferred to nitrocellulose.
Subsequently, the filters were incubated with YL1/2 (A and B,
top), RR90 (A, bottom) or mAb 1680 (B, bottom). The reactivity
with the anti–EEF tag antibody indicates that the polypeptides
are intact and in the correct reading frame. Note that RR90 rec-
ognizes an epitope in the first two immunoglobulin-like domains
of a- and g-filamins, but not in b-filamin. mAb 1680 recognizes
an epitope in the polypeptide a-filamin d16–20, and not in b- or
g-filamin, indicating that it is specific for this isoform. 
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g
 
-Filamin Is the only Filamin Isoform Expressed in 
Differentiating and Adult Human Skeletal Muscle Cells
 
In a previous report, we characterized the expression of
filamins in striated muscle tissues and in cultured cells with
the murine antibody mAb RR90. Here, we characterized
the epitope and isoform specificity of RR90 and of mab
1680 (raised against platelet filamins; Fig. 3, A and B).
Thus, the epitope of RR90 is confined to Ig-like domains 1
and 2 of both, 
 
a
 
- and 
 
g
 
-filamin. In contrast, the corre-
sponding 
 
b-filamin was not recognized (Fig. 3 A). Simi-
larly, mAb 1680 was established to react solely with Ig-like
domains 16–20 of a-filamin (Fig. 3 B).
This enabled a comparison of the staining patterns of an
antibody specific for human a-filamin and RR90, to char-
acterize more precisely which filamin isoforms are ex-
pressed in developing and mature human skeletal muscle
cells, both with respect to temporal expression patterns
and differential spatial distribution. In cross sections of
adult skeletal muscle, both the sarcolemma and the sarco-
plasm of muscle fibers as well as blood vessels were
strongly stained by mAb RR90 (Fig. 4, A–C), whereas the
a-filamin–specific antibody exclusively stained blood ves-
sels (Fig. 4 D). This clearly indicates that the filamin
isoform detected by mAb RR90 in muscle fibers solely
represents g-filamin. In longitudinal sections, cytoplasmic
g-filamin was localized in a distinct cross-striated pattern,
due to its localization in Z-discs (Fig. 4 E). Again, no stain-
ing of muscle fibers was observed with the a-filamin anti-
body (Fig. 4 F), firmly establishing that g-filamin is the
only filamin isoform specifically expressed in myofibers.
In a previous study, Northern and Western blotting
demonstrated that in proliferating cultured human skele-
tal muscle cells, only nonmuscle filamin is expressed and
that within a few hours after the induction of differentia-
tion, the muscle-specific g-filamin isoform can be detected
(van der Ven et al., 2000). These findings were now com-
plemented by immunofluorescence microscopy using an
antibody specific for a-filamin. Thus, a-filamin was re-
vealed solely in proliferating myoblasts and only residual
staining of stress fibre-like structures was observed in
early myotubes 2 d after the induction of differentiation
(Fig. 5, A–D). At later stages, the a-filamin–specific anti-
body did not detect any protein in the myotubes, while
RR90 mainly gave a strong staining of Z-discs (Fig. 5, E–H).
These results make it clear that g-filamin is the filamin iso-
form that is involved in myofibril development.
Ig-like Domain 20 of g-Filamin Including the
Muscle-specific Insertion Is Sufficient for Proper
Z-Disc Targeting
g-Filamin is the only filamin isoform that bears this unique
insertion in its Ig-like domain 20. Its size, 78 amino acids,
must change the three-dimensional structure of this other-
wise z90-residues domain dramatically. Both findings are
indicative of an important and specific function of this in-
sertion in striated muscle. To test for such a function in
myofibril assembly or myofibrillar targeting, the cDNA
encoding Ig-like domain 20 of g-filamin was cloned either
alone or with one or both of the neighboring Ig-like do-
mains in the eukaryotic expression vector pCMV5-T7 (for
positions of clones, see Fig. 1). For comparison, the corre-
sponding Ig-like domain 20 of a-filamin (which is devoid
of this unique insertion) was also cloned in this vector.
Transient transfections were carried out in two myogenic
Figure 4. Immunolocalization of
filamins in sections of human
skeletal muscle tissue. Photomi-
crographs were taken from cryo-
sections of normal human skele-
tal muscle tissue stained with
mAb RR90 (A and B) or double
stained with RR90 (C and E) and
mAb 1680, an antibody specific
for a-filamin (D and F). RR90
detects both sarcoplasmic and
sarcolemmal filamins in cross-
sectioned myofibers (A and B).
In slightly oblique sections, the
typical cytoplasmic staining for
proteins that show a striated,
myofibrillar staining pattern in
longitudinal sections is observed
(A). Double staining of RR90 (C
and E) with mAb 1680 (D and F)
shows that blood vessels that are
known to contain a-filamin are
stained by both antibodies. In
contrast,  a-filamin cannot be de-
tected at the sarcolemma or in
the sarcoplasm of human skeletal
muscle fibers, indicating that the
filamin isoform detected by
RR90 in these cells is exclusively
g-filamin. Bar, 20 mm.The Journal of Cell Biology, Volume 151, 2000 240
cell types. To study targeting of the expressed constructs
to specific subcellular regions, constructs were expressed
in primary neonatal rat cardiomyocytes that upon the time
point of transfection already contain fully assembled myo-
fibrils. Thus, the major fraction of the expressed g-filamin
domain 20 was specifically incorporated into myofibrils of
transfected cardiomyocytes in a regular, cross-striated pat-
tern (Fig. 6 E). No obvious targeting to the cell membrane
was observed. Double immunofluorescence microscopy
using an antibody directed against the immuno-tag of the
expressed protein and an antibody specific for the sarco-
meric isoform of a-actinin (Fig. 6 F) revealed a precise
colocalization of both proteins. This indicated that the Ig-
like domain 20 of g-filamin was incorporated into Z-discs
of cardiac myofibrils. Similarly, transfections of the longer
constructs g-filamin d19/20 (Fig. 6 C) and g-filamin d19-
d21 (A), which include the flanking Ig-like domains, also
resulted in the incorporation of the expressed polypep-
tides in Z-discs, as demonstrated by double staining using
the same combination of antibodies described above (Fig.
6, A–D). Interestingly, both longer constructs seemed to
be targeted to a somewhat narrower region of the Z-disc
in comparison to the construct g-filamin d20, indicating
that at least the addition of Ig-like domain 19 could stabi-
lize the interaction of g-filamin d20 to Z-discs.
The importance of the unique insertion in Ig-like domain
20 of the g-filamin isoform for the interaction with Z-discs
was confirmed by transient expression of a-filamin d20
Figure 5. Immunofluorescence
localization of filamin isoforms in
developing human skeletal mus-
cle cells. The micrographs show
cultured human skeletal muscle
cells differentiated for 0 (A and
B), 2 (C and D), 4 (E and F) or 6
(G and H) d, double stained with
an antibody specific for a-filamin
(left) and mAb RR90 (right).
Note that only in nondifferenti-
ated cells a high level of a-fil-
amin is detected by both antibod-
ies (A and B). After 2 d of
differentiation, RR90 strongly
stains the young myotubes (D),
while the level of a-filamin has
strongly decreased (C), indicat-
ing a clear predominance of the
muscle-specific filamin isoform.
In further developed myotubes,
a-filamin is not detectable (E
and G), and g-filamin seems to
be the only filamin isoform that
is expressed at these develop-
mental stages (F and H). Note
that, after 6 d of differentiation,
g-filamin is localized in a cross-
striated pattern due to its local-
ization in Z-discs. Bar, 20 mm.van der Ven et al. Interactions of g-Filamin/ABP-L in the Z-Disc 241
(i.e., the corresponding insert-less domain from the a-filamin
isoform) in the cardiomyocytes. This construct was distrib-
uted diffusely in transfected cardiomyocytes and did not
show any specific targeting to Z-discs (Fig. 6, G and H).
Subsequently, murine C2C12 cells were used to study the
effects of the expression of the construct g-filamin d20 on
the development of myofibrils. In contrast to the cardio-
myocytes described above, these cells were transfected dur-
ing proliferative stages during which they are devoid of
myofibrils. Differentiation of the cells, and thus myofibril
assembly, therefore occurred simultaneously to the ex-
pression of recombinant polypeptide. The expression of
g-filamin d20 in differentiating C2C12 mouse myoblasts
confirmed the observation described above; i.e., that this
single domain is sufficient for targeting to Z-discs. This do-
main clearly colocalized with the amino terminus of titin at
Z-discs (Fig. 7, C–F). Interestingly, the recombinant pro-
tein was also targeted to nascent myofibrils that did not yet
show a mature cross-striated distribution of Z-disc titin
(Fig. 7, A and B). In none of the transfected cells did the
overexpression of the construct g-filamin d20 lead to an ev-
ident perturbation of myofibril assembly, nor was any tar-
geting to the sarcolemma observed. Surprisingly, the addi-
tion of the neighboring Ig-like domain 21 to the construct
abolished the Z-disc binding capacity of the recombinant
protein. Although some association with premyofibrils was
observed, the polypeptide was never observed in Z-discs
(Fig. 7, G and H). Similar to the observation in cardiomyo-
Figure 6. Expression of recombinant filamin fragments in neona-
tal rat cardiomyocytes. Neonatal rat cardiomyocytes transfected
with constructs encoding T7-tagged g-filamin d19-21 (A and B),
g-filamin d19/20 (C and D), g-filamin d20 (E and F), or a-filamin
d20 (G and H) were fixed and double stained with T7-tag anti-
body (left) and an antibody specific for sarcomeric a-actinin
(right). Note that the recombinant polypeptides g-filamin d19–21
and g-filamin d20/21 colocalize precisely with a-actinin in sharp
striations, indicating that this part of g-filamin is targeted to
Z-discs (A–D, arrows). The single domain g-filamin d20 is also
targeted to the Z-disc region, although the fluorescent stripes ap-
pear less sharp (E and F, arrows). a-filamin d20 is distributed dif-
fusely in the cytoplasm (G) and does not show any specific
targeting to Z-discs or myofibrils in general (H). Bars, 10 mm.
Figure 7. Expression of recombinant filamin fragments in differ-
entiating C2C12 mouse myoblasts. C2C12 cells transfected with
constructs encoding T7-tagged g-filamin d20 (A and F), g-filamin
d20/21 (G and H), or a-filamin d20 (J and K) were allowed to dif-
ferentiate for 2 (A and B) or 4 (C–K) d. Subsequently, they were
fixed and double stained with T7-tag antibody (left) and T12
(right), an antibody specific for a Z-disc epitope of titin. Note that
g-filamin d20 exactly colocalizes with Z-disc titin in nascent myo-
fibrils with immature Z-discs (A and B, arrows), as well as in ma-
ture myofibrils (C–F) where the recombinant protein and Z-disc
epitope of titin are localized in sharp striations (E and F, arrows).
Note that, although g-filamin d20/21 associates with stress fiber–
like structures, it is never found at Z-discs (G and H). a-Filamin
d20 is distributed diffusely in the cytoplasm (J), and does not show
any targeting to immature or mature myofibrils (K). Bars, 20 mm.The Journal of Cell Biology, Volume 151, 2000 242
cytes, a-filamin d20 was diffusely distributed within the cy-
toplasm upon expression in C2C12 cells (Fig. 7, J and K).
g-Filamin Binds to the Z-Disc Protein Myotilin
The yeast two-hybrid system was used to search for bind-
ing partners of the region encompassing the unique inser-
tion in Ig-like domain 20 of g-filamin. Since the single do-
main construct g-filamin fused to the activation domain
turned out to be autoactivating and therefore was not suit-
able for screening, we had to use a bait construct that in-
cluded the flanking Ig-like domains 19 and 21. The yeast
two-hybrid screen yielded z70 HIS3 and b-galactosidase
positive clones from z5  3 105 transformants. Plasmids
were rescued from 20 colonies and the inserts from 12
were partially sequenced. Three of these were found to
contain the full coding region of myotilin, a recently dis-
covered component of the sarcomeric Z-disc (Salmikangas
et al., 1999).
To investigate with greater precision which regions of
g-filamin and myotilin are responsible for the interaction
of both proteins, different subfragments of their cDNAs
were cloned into the yeast two-hybrid bait and pray
vectors (as described in Materials and Methods). All
constructs were analyzed for autoactivation activity. Inter-
actions were tested by b-galactosidase assays in cotrans-
formed L40 yeast cells. The pair of Ig-like filamin domains
20 and 21 (g-filamin d20/21) was found to be negative in
these assays. Since the bait containing domains 19 and 20
(g-filamin d19/20) was autoactivating, the original three-
domain filamin fragment was the smallest fragment that
showed binding to full-length myotilin (Fig. 8). Similarly,
myotilin constructs were generated that contained either
the unique amino terminal 248 amino acids (MYOT-S) or
the subsequent two Ig-like domains (MYOT-I, residues
251–447). In the assay, only the fragment MYOT-I was
positive (Fig. 8). Thus, this novel protein–protein interac-
tion could be located to g-filamin Ig-like domains 19–21
and to the Ig-like domains of myotilin.
Coimmunoprecipitation and Double-Transfection 
Experiments Confirm the Association of g-Filamin 
d19–21 with the Immunoglobulin Domains of Myotilin
The yeast two-hybrid data were confirmed by independent
biochemical binding assays. Distinct subfragments of g-fil-
amin comprising either the insert-bearing domain 20 or
this domain with one or both neighboring domains were
expressed with a carboxyterminal EEF-tag in E. coli. Only
two of the recombinant polypeptides ( g-filamin d19–21
and  g-filamin d20/21) could be purified in a native, soluble
form (Fig. 9 A). Likewise, the portion of myotilin that
comprises its Ig-like domains was also bacterially ex-
pressed, however, with an amino-terminally situated T7
tag (construct MYOT-I; Fig. 9 A). This combination of
two differentially tagged constructs allowed us to investi-
gate the binding by immunoprecipitation experiments. In
this assay, only the three-domain filamin construct (g-fil-
amin d19–21) showed binding to the myotilin Ig-domains
(Fig. 9, B and C). Immunocomplexes were precipitated
both with the anti–T7 tag and the anti–EEF tag antibodies
(Fig. 9, B and C, arrows). In contrast, the recombinant
polypeptides g-filamin d20/21 and g-filamin d24 were not
coprecipitated with myotilin (Fig. 9 B).
The validity of the observed association of myotilin with
g-filamin was further strengthened by coimmunoprecipita-
tion experiments from yeast cells that were coexpressing
the myotilin immunoglobulin domains fused to GAL 4AD
and the HA tag, and g-filamin d19–21 fused to the LexA
protein. Both antibodies specific for the HA tag and anti-
bodies recognizing the immunoglobulin domains of myoti-
lin specifically precipitated protein complexes also con-
taining the expressed g-filamin fragment (Fig. 9 D). In
contrast, the filamin fragment was not coprecipitated with
GAL 4AD–HA tag alone, substantiating the specificity of
the interaction.
Further evidence for the interaction between myotilin
and g-filamin was achieved by double transfection of non-
muscle cells with GFP-tagged full-length myotilin and T7-
tagged g-filamin d19–21. Whereas myotilin expressed in
Ptk2 cells showed an obvious colocalization with a-actinin
in stress fibers (Fig. 10, A and B), cells double transfected
with the myotilin construct and g-filamin d19–21 showed a
dramatically altered myotilin localization in aggregates to-
gether with the truncated g-filamin polypeptide (C and
D). Double transfection of GFP–a-actinin together with
g-filamin d19–21 did not inhibit the targeting of a-actinin
to stress fibres (Fig. 10, E and F), indicating that the GFP
tag plays no role in the observed association.
Figure 8. Characterization of the interaction of g-filamin with
myotilin. Yeast cells pretransformed with g-filamin d20/21 or g-fil-
amin d19–21 in pLexPd were transformed with the empty prey
vector (pGADPd) or with the region of the myotilin cDNA en-
coding its complete polypeptide (MYOT-SIT), its serine rich do-
main (MYOT-S), or the immunoglobulin domains (MYOT-I) in
pGADPd. (A) In four independent colonies double transformed
with g-filamin d19–21 and MYOT-SIT, b-galactosidase activity
was restored, indicating an interaction between both polypep-
tides. This reactivity was absent in all colonies of yeast cells trans-
formed with g-filamin d20/21 and MYOT-SIT. (B) Two inde-
pendent yeast colonies cotransformed with g-filamin d19–21 or
g-filamin d20/21, and truncated myotilin fragments. Note that
only in yeast cells cotransformed with g-filamin d19–21 and
MYOT-I or MYOT-SIT b-galactosidase reactivity was restored.
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Overexpression of the Immunoglobulin Domains of 
Myotilin, but not of Full-Length Myotilin, Has a 
Dominant Negative Effect on Myofibril Assembly
To gain insight in the possible function of the interaction
between g-filamin and myotilin, the immunoglobulin do-
mains of myotilin (MYOT-I) and full-length myotilin
(MYOT-SIT) were cloned into the pCMV5-T7 vector, and
overexpressed in C2C12 cells that were subsequently al-
lowed to differentiate. The effect of the overexpression of
both recombinant proteins was studied immunocytochem-
ically by double staining the transfected cells with antibod-
ies against the immunotag and T12, our antibody against
Z-disc titin. This allowed us to study Z-disc assembly in
the presence of the overexpressed polypeptides. In cells
transfected with MYOT-SIT, the recombinant protein was
detected in numerous large myotubes, were it colocalized
with Z-disc titin during all developmental stages (Fig. 11,
G and H). This indicated that MYOT-SIT is targeted to
Figure 9. Coimmunoprecipitation of filamin and myotilin fragments. (A) Coomassie blue–stained SDS gel of recombinant protein frag-
ments used for coimmunoprecipitation experiments. The identity of the polypeptides is indicated above each lane. (B and C) T7-tagged
MYOT-I and EEF-tagged g-filamin fragments alone (control) or mixed with MYOT-I (MYOT-I) were incubated with anti–EEF anti-
body (B) or anti–T7-tag antibody (C), immunoprecipitated as described in Materials and Methods, and subjected to SDS-PAGE and
Western blotting. For immunodetection of binding partners of the precipitated polypeptide, anti–T7-tag antibody (B) or anti–EEF anti-
body (C) were used. Arrowheads indicate positions of proteins that are specifically coprecipitated. Note that MYOT-I is coprecipitated
with g-filamin d19–21, but not with g-filamin d20/21 or g-filamin d24 (B), and that g-filamin d19–21 is coprecipitated with MYOT-I (C).
(D) Coimmunoprecipitation from yeast cells double transfected with an empty Lex vector (Lex) or the pLex vector containing g-filamin
d19–21, together with an empty pACT2-HA vector (HA) or this vector with MYOT-IT (HA-MYOT-IT), as indicated above the lanes.
In the left two lanes, expression of the proteins was confirmed by Western blotting using an anti–HA or anti–LexA antibody. In the
middle two lanes, the complexes immunoprecipitated with the anti–HA antibody were separated and stained with the anti–LexA anti-
body to detect Lex-g-filamin d19–21. Note that Lex-g-filamin d19–21 is only coprecipitated with HA-MYOT-I and not with HA alone.
In the right two lanes, complexes immunoprecipitated with the anti–myotilin antibody were separated and stained with the anti–LexA
antibody to detect Lex-g-filamin d19–21. Note that Lex-g-filamin d19–21 is again coprecipitated with HA-MYOT-I. No signal is ob-
tained if the cells are transfected with the empty LexA vector.The Journal of Cell Biology, Volume 151, 2000 244
developing and mature Z-discs without obviously disturb-
ing myofibril assembly. Transfection of the MYOT-I con-
struct, however, resulted in a dramatic effect on myofibril-
lar assembly. Although the recombinant polypeptide was
targeted to immature Z-discs (Z-bodies; Fig. 11, A and B),
transfected myotubes with fully developed Z-discs were
never observed. Instead, irregular filamentous structures
(Fig. 11, C and D) or amorphous aggregates (E and F)
containing MYOT-I and a major part of titin were present
in transfected cells.
Discussion
The development of myofibrils in differentiating muscle
cells is one of the most impressive macromolecular assem-
bly processes in nature. It involves the interaction of a
great number of different proteins that has to be precisely
controlled both in terms of space and time (Franzini-Arm-
strong and Fischman, 1994; Squire, 1997). Many of these
proteins occur in multiple isoforms whose expression
patterns are fundamentally different and are therefore
thought to fulfill highly specialized roles (Pette and
Staron, 1997). The filamins are an example for such a gene
family that became evident only rather recently. In the
chicken system, the existence of several distinct filamin
isoforms was suspected already several years ago, mainly
due to differentially reacting antibodies (Gomer and Laz-
arides, 1981, 1983; Price et al., 1994). Further insights into
the differential functions of the avian isoforms has been
hindered by the lack of primary sequence information,
with only one isoform so far cloned (Barry et al., 1993).
Similar studies in mammalian systems relied for a long
time on antibodies reacting with only a single polypeptide
that on top could not be identified in striated muscles
(Brown and Binder, 1993). Molecular genetic studies
pointed at the existence of an additional isoform ex-
pressed in human skeletal muscle that was called ABP-L
(Maestrini et al., 1993). Its complete cDNA was cloned re-
Figure 10. Expression of filamin, myotilin and a-actinin in non-
muscle cells. Ptk2 cells were transfected with GFP-tagged
MYOT-SIT alone (A and B), GFP-tagged MYOT-SIT together
with T7-tagged g-filamin d19–21 (C and D), or GFP-tagged a-acti-
nin and T7-tagged g-filamin d19–21 (E and F). The T7-tagged re-
combinant protein was visualized by staining with the anti–T7-
tag antibody (D and F). Endogenous a-actinin was stained with
BM-75.2 recognizing all isoforms of a-actinin (B). Full-length
myotilin is targeted to stress fibers, where it colocalizes with en-
dogenous a-actinin (A and B). Note that if, in the same cell, g-fil-
amin d19–21 is expressed, the localization of MYOT-SIT is dra-
matically changed, and the protein is found in aggregates
together with g-filamin d19–21 (C and D). In contrast, the local-
ization of GFP-tagged a-actinin, which is also targeted to stress
fibers, is not changed upon coexpression of g-filamin d19–21 (E
and F), indicating that MYOT-I and not the GFP tag interacts
with g-filamin d19–21. Bars, 10 mm.
Figure 11. Expression of recombinant myotilin fragments in dif-
ferentiating C2C12 mouse myoblasts. C2C12 cells transfected with
constructs encoding T7-tagged immunoglobulin domains of myo-
tilin (MYOT-I; A and F), or full-length myotilin (MYOT-SIT; G
and H) were allowed to differentiate for 4 d. Subsequently, they
were fixed and double stained with T7-tag antibody (left) and T12
(right), an antibody specific for a Z-disc epitope of titin. Note that
MYOT-SIT exactly colocalizes with Z-disc titin in nascent myo-
fibrils with immature Z-discs as well as in mature myofibrils (G
and H). MYOT-I associates with stress fiber–like structures (A
and B), but it is never found in Z-discs. Moreover, myotubes ex-
pressing MYOT-I do not develop myofibrils. Instead, the myo-
fibrillar proteins are colocalized with MYOT-I in filamentous bun-
dles (C and D) or amorphous aggregates (E and F). Bar, 20 mm.van der Ven et al. Interactions of g-Filamin/ABP-L in the Z-Disc 245
cently and the protein was renamed g-filamin (Xie et al.,
1998). We have succeeded in obtaining an antibody that
reacts with both filamin isoforms, which made it feasible to
approach the question of the different roles of these pro-
teins in muscle (van der Ven et al., 2000). Here we used
this mAb (called RR90) in combination with an antibody
that we could show to be specific for a-filamin, with the
idea that a subtraction of both antibody labels might yield
firm statements about the distribution of the individual fil-
amin isoforms. Thus, in adult striated muscle fibers, g-fil-
amin is expressed while nonmuscle a-filamin is limited to
blood vessels and connective tissue cells (Fig. 4). This still
leaves the interesting question unanswered: why, within
the myofibers, g-filamin shows a dual pattern of distri-
bution? In accordance with cell fractionation studies
(Thompson et al., 2000), we found the majority of filamin
in the myofibrils that correspond to the particulate sarco-
plasmic fraction; conversely, a small fraction of g-filamin
was located at the sarcolemma (Fig. 4). We propose that
this differential targeting, which at the same time implies
distinct functions, could be the result of alternatively
spliced  g-filamin variants. This idea is supported by a pro-
visional genetic analysis that revealed short alternatively
spliced exons for a-filamin (Maestrini et al., 1993). Defini-
tive proof, however, will require the establishment of the
complete genomic structure of the FLNC gene and the
subsequent elucidation of peptide-specific antibodies. In
line with this view, quite distinct staining patterns were ob-
served in developing chicken muscle cells. On the one
hand, filamin was first located in stress fiber–like struc-
tures, and then disappeared for several days, and finally
reappeared at the periphery of Z-discs (Gomer and Laz-
arides, 1981). On the other hand, filamin was detected in
the developing chicken heart only from the 14 somite
stage onwards; i.e. at a time when functional myofibrils in
the beating heart exist already for z4 h (Price et al., 1994).
It is very likely that the antibodies used in these studies did
not reflect the complete spectrum of filamin isoforms that
can be expected to be expressed in avian tissues.
The subtractive antibody labeling approach was also used
on developing skeletal muscle cells in culture. This clearly
demonstrated not only that g-filamin is expressed within a
few hours subsequent to the induction of muscle differenti-
ation (see also van der Ven et al., 2000), but also that solely
this isoform participates in the striking reorganization of
the actin cytoskeleton during myofibril formation (Fig. 5).
The specific function of filamin in myofibrils cannot be
solely attributed to its well-documented capacity to cross-
link actin filaments, particularly since this region shows
very little variability between the isoforms. Therefore, dif-
ferent functions must be determined in other, more di-
verse parts of the molecule. The region that mainly at-
tracted our attention was the unique insertion of 78 amino
acids located within Ig-like domain 20. We show here that
this insertion, which previously was shown to be specifi-
cally expressed in differentiated muscle (Xie et al., 1998;
van der Ven et al., 2000), is encoded by a single extra exon
that is differentially spliced (Fig. 2). Transfection studies
and yeast two-hybrid screenings were used to address the
specific function of this molecular region. The transfection
studies were aimed at elucidating its role for the subcellu-
lar targeting of filamin in muscle cells. Previous studies us-
ing either the a- or g-filamin isoforms have emphasized
their membrane association (see Introduction). Here, we
identify for the first time a myofibrillar targeting signal
within  g-filamin that is functional in both cardiac and skel-
etal muscle cells. Since in both cell types myofibrils were
assembled normally in the presence of the overexpressed
recombinant protein, it does not seem to exert a dominant
negative effect on this process, at least at the time scale of
our experiments. We also believe it is justified to assume
that this signal must reside in the unique domain 20 inser-
tion because a-filamin (which does not contain this inser-
tion) does not show any specific localization upon overex-
pression in muscle cells.
The strict targeting of Ig-like domain 20 of g-filamin
urged us to search for a myofibrillar protein that might
specifically interact with it. Yeast two-hybrid screens iden-
tified the recently discovered protein myotilin (Salmikan-
gas et al., 1999) as a binding partner for g-filamin, and
three independent experiments (coimmunoprecipitation
experiments using recombinant fragments, coimmunopre-
cipitation from double-transfected yeast cells, and double
transfection of nonmuscle cells) confirmed and further
confined this interaction (Figs. 9 and 10). Since myotilin
was previously shown to bind a-actinin, we assume that
the function of this Z-disc protein is the indirect anchorage
of g-filamin, which is localized at the periphery of sarco-
meric Z-discs (Thompson et al., 2000; van der Ven et al.,
2000), to a-actinin in the central Z-disc.
In contrast to the overexpression of the myotilin binding
part of g-filamin, the overexpression of the g-filamin–
binding region of myotilin had a dramatic effect on the as-
sembly of myofibrils in differentiating C2C12 myotubes.
This implies that the amino terminal part of myotilin that
is lacking in this construct and is known to contain an a-acti-
nin binding site (Salmikangas et al., 1999) plays an im-
portant role in the control of myofibrillar assembly. Ob-
viously, the interaction g-filamin–myotilin–a-actinin is
disturbed by overexpression of this truncated myotilin
fragment that is still able to associate with g-filamin. This
regulatory role is further strengthened by the observation
that overexpression of full-length myotilin does not result
in abnormal myofibrillogenesis. Thus, it seems that the
a-actinin–binding part of the myotilin molecule is indis-
pensable for the proper function of the protein.
The identification of myotilin as a g-filamin binding part-
ner described in this report, together with earlier observa-
tions that g-filamin binds g- and d-sarcoglycan (Thompson
et al., 2000) is particularly interesting with regard to recent
findings on LGMD. Mutations in the genes encoding all
three binding partners cause LGMD (Noguchi et al., 1995;
Nigro et al., 1996; Hauser et al., 2000). Furthermore, the
FLNC gene itself has been mapped to an LGMD candi-
date region on chromosome 7 (Speer et al., 1999). Inter-
estingly, caveolin-1 was recently identified as a binding
partner of a-filamin (Stahlhut and van Deurs, 2000). Con-
sidering the high degree of similarity of the isoforms of
both proteins, the muscle isoform of caveolin (caveolin-3,
which in turn is a further LGMD gene), can be assumed to
interact in a similar way with muscle filamin, although de-
finitive proof is still lacking.
Until recently, this genetically heterogeneous disease
has been attributed essentially to mutations of the genes
encoding sarcolemmal proteins such as a-, b-, g-, and
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Bushby, 1999; Toniolo and Minetti, 1999). In LGMD 2C
and LGMD 2F, which are caused by mutations in the g-
and d-sarcoglycan genes, respectively, the fraction of g-fil-
amin that is localized to the sarcolemma is highly in-
creased. Considering these observations, the traditional
role of filamins in the submembraneous cytoskeleton and
the fact that the vast majority of other identified interac-
tors of filamins until now are mainly membrane-associated
proteins, an LGMD model was suggested that favors a cy-
clic translocation of g-filamin from membrane attachment
sites to intracellular locations. In LGMD 2C and 2F and
other muscle diseases characterized by abnormalities in
both sarcoglycans this cycling was supposed to be dis-
turbed (Thompson et al., 2000).
Our finding that the muscle-specific isoform of filamin
specifically binds myotilin, adds an interesting facet to the
theme of LGMD: mutations in myotilin, a sarcomeric
Z-disc protein that interacts with a-actinin, were sug-
gested to cause LGMD1A (Hauser et al., 2000). Filamin is
therefore the first protein identified that can link mem-
brane-related effects to myofibrillar defects. This finding
strongly corroborates the notion that, in LGMD myofi-
bers, large amounts of filamin accumulate at the sarco-
lemma (Thompson et al., 2000). LGMD may therefore be
caused by two interdependent molecular events: one, the
destabilization of membrane attachment complexes and,
the other, the weakening of myofibrils and/or myofibrillar
connections particularly at the Z-disc. The recently de-
scribed LGMD 2G-causing mutations in the Z-disc pro-
tein telethonin (Moreira et al., 2000), a protein that has
been implied to be involved in signaling events during
myofibril development (Mayans et al., 1998; Mues et al.,
1998), strongly supports this assumption.
The relationship of g-filamin with both sarcolemmal and
myofibrillar proteins, which are involved in LGMD, is
highly indicative of an important function for this protein
in signaling processes between the sarcolemma and myo-
fibrils. In line with this idea, patients were identified
whose disease phenotype showed genetic linkage to chro-
mosome 7q (Speer et al., 1999), a chromosomal region that
also includes the FLNC gene (Maestrini et al., 1993; Xie et
al., 1998). This increases the probability that defects in the
FLNC gene itself might cause LGMD in patients who do
not have mutations in any of the known LGMD genes.
Our work might therefore provide a molecular basis to de-
fine a novel signaling pathway from the sarcolemma to the
myofibril. Disturbances of this pathway at any point may
result in essentially the same clinical manifestation in the
form of LGMD.
We gratefully acknowledge the technical assistance of B. Mai and A. Guh-
lan. The authors thank Dr. M. Gautel for help with setting up the yeast two-
hybrid system, Drs. S. Shapiro and T. Takafuta for the b-filamin cDNA, Dr.
C. Otey for the nonmuscle a-actinin construct, Dr. J. Wehland for the dona-
tion of mAb YL1/2, and Dr. I. Blümcke for help with confocal microscopy.
Submitted: 18 April 2000
Revised: 1 August 2000
Accepted: 30 August 2000
References
Abd-el-Basset, E.M., I. Ahmed, and S. Fedoroff. 1991. Actin and actin-binding
proteins in differentiating astroglia in tissue culture. J. Neurosci. Res. 30:1–17.
Auerbach, D., S. Bantle, S. Keller, V. Hinderling, M. Leu, E. Ehler, and J.C. Per-
riard. 1999. Different domains of the M-band protein myomesin are involved
in myosin binding and M-band targeting. Mol. Biol. Cell. 10:1297–1308.
Ayscough, K.R. 1998. In vivo functions of actin-binding proteins. Curr. Opin.
Cell Biol. 10:102–111.
Barry, C.P., J. Xie, V. Lemmon, and A.P. Young. 1993. Molecular characteriza-
tion of a multipromoter gene encoding a chicken filamin protein. J. Biol.
Chem. 268:25577–25586.
Bröcker, F., W. Bardenheuer, L. Vieten, K. Jülicher, N. Werner, G. Marguitan, D.
Michael, B. Opalka, and J. Schütte. 1999. Assignment of human filamin gene
FLNB to human chromosome band 3p14.3 and identification of YACs contain-
ing the complete FLNB transcribed region. Cytogenet. Cell Genet. 85:267–268.
Brotschi, E.A., J.H. Hartwig, and T.P. Stossel. 1978. The gelation of actin by ac-
tin-binding protein. J. Biol. Chem. 253:8988–8993.
Brown, K.D., and L.I. Binder. 1993. Expression of the cytoskeletal-associated
protein filamin in adult rat organs. Exp. Cell Res. 209:325–332.
Bushby, K.M. 1999. The limb-girdle muscular dystrophies-multiple genes, mul-
tiple mechanisms. Hum. Mol. Genet. 8:1875–1882.
Cunningham, C.C., J. B. Gorlin, D.J. Kwiatkowski, J.H. Hartwig, P.A. Janmey,
H. Byers, and T.P. Stossel. 1992. Actin-binding protein requirement for cor-
tical stability and efficient locomotion. Science. 255:325–327.
Fox, J.E. 1985. Identification of actin-binding protein as the protein linking the
membrane skeleton to glycoproteins on platelet plasma membranes. J. Biol.
Chem. 260:11970–11977.
Franzini-Armstrong, C., and D.A. Fischman. 1994. Morphogenesis of skeletal
muscle fibres. In Myology. A.K. Engel and C. Franzini-Armstrong, editors.
McGraw Hill, Inc., New York. 74–96. 
Fürst, D.O., M. Osborn, R. Nave, and K. Weber. 1988. The organization of titin
filaments in the half-sarcomere revealed by monoclonal antibodies in immu-
noelectron microscopy; a map of ten non-repetitive epitopes starting at the
Z line extends close to the M line. J. Cell Biol. 106:1563–1572.
Gariboldi, M., E. Maestrini, F. Canzian, G. Manenti, L. De Gregorio, S. Ri-
vella, A. Chatterjee, G.E. Herman, N. Archidiacono, and R. Antonacci.
1994. Comparative mapping of the actin-binding protein 280 genes in human
and mouse. Genomics. 21:428–430.
Gomer, R.H., and E. Lazarides. 1981. The synthesis and deployment of filamin
in chicken skeletal muscle. Cell. 23:524–532.
Gomer, R.H., and E. Lazarides. 1983. Highly homologous filamin polypeptides
have different distributions in avian slow and fast muscle fibers. J. Cell Biol.
97:818–823.
Goncharova, E.J., Z. Kam, and B. Geiger. 1992. The involvement of adherens
junction components in myofibrillogenesis in cultured cardiac myocytes. De-
velopment (Camb.). 114:173–183.
Gorlin, J.B., E. Henske, S.T. Warren, C.B. Kunst, M. D’Urso, G. Palmieri, J.H.
Hartwig, G. Bruns, and D.J. Kwiatkowski. 1993. Actin-binding protein
(ABP-280) filamin gene (FLN) maps telomeric to the color vision locus
(R/GCP) and centromeric to G6PD in Xq28. Genomics. 17:496–498.
Gorlin, J.B., R. Yamin, S. Egan, M. Stewart, T.P. Stossel, D.J. Kwiatkowski,
and J.H. Hartwig. 1990. Human endothelial actin-binding protein (ABP-280,
nonmuscle filamin): a molecular leaf spring. J. Cell Biol. 111:1089–1105.
Grönholm, M., M. Sainio, F. Zhao, L. Heiska, A. Vaheri, and O. Carpén. 1999.
Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor sup-
pressor protein merlin and the ERM protein ezrin. J. Cell Sci. 112:895–904.
Hauser, M.A, S.K. Horrigan, P. Salmikangas, U.M. Torian, K.D. Viles, R. Dancel,
R.W. Tim, A. Taivainen, L. Bartoloni, J.M. Gilchrist, et al. 2000. Myotilin is
mutated in limb girdle muscular dystrophy 1A. Hum. Mol. Genet. 9:2141–2147.
Hock, R.S. 1999. Filamin. In Guidebook to the Cytoskeletal and Motor Proteins.
T. Kreis and R. Vale, editors. Oxford University Press. Oxford, UK. 94–97.
Komiyama, M., T. Soldati, P. von Arx, and J.-C. Perriard. 1996. The intracom-
partmental sorting of myosin alkali light chain isoproteins reflects the se-
quence of developmental expression as determined by double epitope-tag-
ging competition. J. Cell Sci. 109:2089–2099.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature. 227:680–685.
Liu, G., L. Thomas, R.A. Warren, C.A. Enns, C.C. Cunningham, J.H. Hartwig,
and G. Thomas. 1997. Cytoskeletal protein ABP-280 directs the intracellular
trafficking of furin and modulates proprotein processing in the endocytic
pathway. J. Cell Biol. 139:1719–1733.
Loo, D.T., S.B. Kanner, and A. Aruffo. 1998. Filamin binds to the cytoplasmic
domain of the b1-integrin. J. Biol. Chem. 273:23304–23312.
Maestrini, E., C. Patrosso, M. Mancini, S. Rivella, M. Rocchi, M. Repetto, A.
Villa, A. Frattini, M. Zoppé, P. Vezzoni, and D. Toniolo. 1993. Mapping of
two genes encoding isoforms of the actin binding protein ABP-280, a dystro-
phin like protein, to Xq28 and to chromosome 7. Hum. Mol. Genet. 2:761–766.
Marti, A., Z. Luo, C. Cunningham, Y. Ohta, J. Hartwig, T.P. Stossel, J.M. Kyri-
akis, and J. Avruch. 1997. Actin-binding protein-280 binds the stress-activated
protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis fac-
tor-alpha activation of SAPK in melanoma cells. J. Biol. Chem. 272:2620–2628.
Mayans, O., P.F.M. van der Ven, M. Wilm, A. Mues, P. Young, D.O. Fürst, M.
Wilmanns, and M. Gautel. 1998. Structural basis for activation of the titin ki-
nase domain during myofibrillogenesis. Nature. 395:863–869.
Meyer, S.C., S. Zuerbig, C.C. Cunningham, J.H. Hartwig, T. Bissell, K. Gard-
ner, and J.E.B. Fox. 1997. Identification of the region in actin-binding pro-
tein that binds to the cytoplasmic domain of glycoprotein Iba. J. Biol. Chem.
272:2914–2919.
Mittal, B., J.M. Sanger, and J.W. Sanger. 1987. Binding and distribution of fluo-
rescently labeled filamin in permeabilized and living cells. Cell Motil. Cy-van der Ven et al. Interactions of g-Filamin/ABP-L in the Z-Disc 247
toskelet. 8:345–359.
Moreira, E.S., T.J. Wiltshire, G. Faulkner, A. Nilforoushan, M. Vainzof, O.T.
Suzuki, G. Valle, R. Reeves, M. Zatz, M.R. Passos-Bueno, and D.E. Jenne.
2000. Limb-girdle muscular dystrophy type 2G is caused by mutations in the
gene encoding the sarcomeric protein telethonin. Nat. Genet. 24:163–166.
Mues, A., P.F.M. van der Ven, P. Young, D.O. Fürst, and M. Gautel. 1998. Two
immunoglobulin-like domains of the Z-disc portion of titin interact in a con-
formation-dependent way with telethonin. FEBS Lett. 428:111–114.
Nigro, V., E. de Sa Moreira, G. Piluso, M. Vainzof, A. Belsito, L. Politano,
A.A. Puca, M.R. Passos-Bueno, and M. Zatz. 1996. Autosomal recessive
limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the
delta-sarcoglycan gene. Nat. Genet. 14:195–198.
Noguchi, S., E.M. McNally, K. Ben Othmane, Y. Hagiwara, Y. Mizuno, M.
Yoshida, H. Yamamoto, C.G. Bönnemann, E. Gussoni, P.H. Denton, et al.
1995. Mutations in the dystrophin-associated protein gamma-sarcoglycan in
chromosome 13 muscular dystrophy. Science. 270:819–822.
Obermann, W.M.J., M. Gautel, K. Weber, and D.O. Fürst. 1997. Molecular
structure of the sarcomeric M band: mapping of titin and myosin binding do-
mains in myomesin and the identification of a potential regulatory phosphor-
ylation site in myomesin. EMBO (Eur. Mol. Biol. Organ.) J. 16:211–220.
Obermann, W.M.J., P.F.M. van der Ven, F. Steiner, K. Weber, and D.O. Fürst.
1998. Mapping of a myosin-binding domain and a regulatory phosphoryla-
tion site in M-protein, a structural protein of the sarcomeric M band. Mol.
Biol. Cell. 9:829–840.
Okita, J.R., D. Pidard, P.J. Newman, R.R. Montgomery, and T.J. Kunicki. 1985.
On the association of glycoprotein Ib and actin-binding protein in human
platelets. J. Cell Biol. 100:317–321.
Pette, D., and R.S. Staron. 1997. Mammalian skeletal muscle fiber type transi-
tions. Int. Rev. Cytol. 170:143–223.
Pfaff, M., S. Liu, D.J. Erle, and M.H. Ginsberg. 1998. Integrin b cytoplasmic do-
mains differentially bind to cytoskeletal proteins. J. Biol. Chem. 273:6104–6109.
Price, M.G., D.R. Caprette, and R.H. Gomer. 1994. Different temporal patterns
of expression result in the same type, amount, and distribution of filamin
(ABP) in cardiac and skeletal myofibrils. Cell Motil. Cytoskelet. 27:248–261.
Saiki, R.K., S.J. Scharf, F. Faloona, G.T. Mullis, and H.A. Ehrlich. 1985. Enzy-
matic amplification of beta-globin genomic sequences and restriction site
analysis for diagnosis of sickle cell anemia. Science. 230:1350–1354.
Salmikangas, P., O.M. Mykkänen, M. Gronholm, L. Heiska, J. Kere, and O.
Carpén. 1999. Myotilin, a novel sarcomeric protein with two Ig-like domains,
is encoded by a candidate gene for limb-girdle muscular dystrophy. Hum.
Mol. Genet. 8:1329–1336.
Sen, A., P. Dunnmon, S.A. Henderson, R.D. Gerard, and K.R. Chien. 1988.
Terminally differentiated neonatal rat myocardial cells proliferate and main-
tain specific differentiated functions following expression of SV40 large T
antigen. J. Biol. Chem. 263:19132–19136.
Sharma, C.P., R.M. Ezzell, and M.A. Arnaout. 1995. Direct interaction of filamin
(ABP-280) with the beta 2-integrin subunit CD18. J. Immunol. 154:3461–3470.
Small, J.V., D.O. Fürst, and J. DeMey. 1986. Localization of filamin in smooth
muscle. J. Cell Biol. 102:210–220.
Speer, M.C., J.M. Vance, J.M. Grubber, F.L. Graham, J.M. Stajich, K.D. Viles,
A. Rogala, R. McMichael, J. Chutkow, C. Goldsmith, R.W. Tim, and A. Peri-
cak-Vance. 1999. Identification of a new autosomal dominant limb-girdle
muscular dystrophy locus on chromosome 7. Am. J. Hum. Genet. 64:556–562.
Squire, J.M. 1997. Architecture and function in the muscle sarcomere. Curr.
Opin. Struct. Biol. 7:247–257.
Stahlhut, M., and B. van Deurs. 2000. Identification of filamin as a novel ligand
for caveolin-1: evidence for the organization of caveolin-1–associated mem-
brane domains by the actin cytoskeleton. Mol. Biol. Cell. 11:325–337.
Stenmark, H., G. Vitale, O. Ullrich, and M. Zerial. 1995. Rabaptin-5 is a direct
effector of the small GTPase Rab5 in endocytic membrane fusion. Cell. 83:
423–432.
Takafuta, T., G. Wu, G.F. Murphy, and S.S. Shapiro. 1998. Human beta-filamin
is a new protein that interacts with the cytoplasmic tail of glycoprotein Ib al-
pha. J. Biol. Chem. 273:17531–17538.
Thompson, T.G., Y.M. Chan, A.A. Hack, M. Brosius, M. Rajala, H.G.W. Lidow,
E.M. McNally, S. Watkins, and L.M. Kunkel. 2000. Filamin 2 (FLN2): a mus-
cle-specific sarcoglycan interacting protein. J. Cell Biol. 148:115–126.
Toniolo, D., and C. Minetti. 1999. Muscular dystrophies: alterations in a limited
number of cellular pathways? Curr. Opin. Genet. Dev. 9:275–282.
van der Ven, P.F.M., W.M.J. Obermann, B. Lemke, M. Gautel, K. Weber, and
D.O. Fürst. 2000. The characterization of muscle filamin isoforms suggests a
possible role of ABP-L/g-filamin in sarcomeric Z-disc formation. Cell Motil.
Cytoskelet. 45:149–162.
van der Ven, P.F.M., G. Schaart, H.J.E. Croes, P.H.K. Jap, L.A. Ginsel, and
F.C.S. Ramaekers. 1993. Titin aggregates associated with intermediate fila-
ments align along stress fiber–like structures during human skeletal muscle
cell differentiation. J. Cell Sci. 106:749–759.
van der Ven, P.F.M., G. Schaart, P.H.K. Jap, R.C.A. Sengers, A.M. Stadhoud-
ers, and F.C.S. Ramaekers. 1992. Differentiation of human skeletal muscle
cells in culture: maturation as indicated by titin and desmin striation. Cell
Tissue Res. 270:189–198.
Vojtek, A.B., S.M. Hollenberg, and J.A. Cooper. 1993. Mammalian Ras inter-
acts directly with the serine/threonine kinase Raf. Cell. 74:205–214.
Wang, K., J.F. Ash, and S.J. Singer. 1975. Filamin, a new high-molecular–
weight protein found in smooth muscle and non-muscle cells. Proc. Natl.
Acad. Sci. USA. 72:4483–4486.
Wang, K., and S.J. Singer. 1977. Interaction of filamin with F-actin in solution.
Proc. Natl. Acad. Sci. USA. 74:2021–2025.
Wang, Q., W.F. Patton, E.T. Chiang, H.B. Hechtman, and D. Shepro. 1996. Fil-
amin translocation is an early endothelial cell inflammatory response to
bradykinin: regulation by calcium, protein kinases, and protein phosphatases.
J. Cell. Biochem. 62:383–396.
Wehland, J., M.C. Willingham, and I.V. Sandoval. 1983. A rat monoclonal antibody
reacting specifically with the tyrosylated form of alpha-tubulin. I. Biochemical
characterization, effects on microtubule polymerization in vitro, and microtu-
bule polymerization and organization in vivo. J. Cell Biol. 97:1467–1475.
Xie, Z., W. Xu, E.W. Davie, and D.W. Chung. 1998. Molecular cloning of hu-
man ABPL, an actin-binding protein homologue. Biochem. Biophys. Res.
Commun. 251:914–919.
Xu, W.F., Z. Xie, D.W. Chung, and E.W. Davie. 1998. A novel human actin-
binding protein homologue that binds to platelet glycoprotein Ib alpha.
Blood.  92:1268–1276.
Young, P., C. Ferguson, S. Banuelos, and M. Gautel. 1998. Molecular structure
of the sarcomeric Z-disk: two types of titin interactions lead to an asymmet-
rical sorting of a-actinin. EMBO (Eur. Mol. Biol. Organ.) J. 17:1614–1624.
Zhang, W., S.W. Han, D.W. McKeel, A. Goate, and J.Y. Wu. 1998. Interaction
of presenilins with the filamin family of actin-binding proteins. J. Neurosci.
18:914–922.